Rapid Dose Therapeutics Corp.
RDTCF
$0.09
$0.0341.67%
OTC PK
| 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 29.01% | 56.32% | 17.64% | 25.06% | 44.19% |
| Total Depreciation and Amortization | -8.30% | 107.19% | 159.14% | 168.66% | 56.84% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -40.14% | -93.41% | -5.74% | 5.70% | -47.91% |
| Change in Net Operating Assets | 214.06% | 38.32% | -84.02% | -126.08% | -89.50% |
| Cash from Operations | 110.30% | 13,628.13% | 1.34% | -0.10% | 31.95% |
| Capital Expenditure | -- | 100.00% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 46,810.00% | -- | -- | -- |
| Total Debt Issued | -86.61% | -- | -- | 2,303.67% | 389.08% |
| Total Debt Repaid | -- | -786.04% | 76.18% | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -108.56% | -18,488.28% | 27.30% | 18.93% | -17.37% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -94.02% | -430.37% | 413.48% | -52.65% | 204.55% |